title: Diagnosis and treatment of invasive fungal infections in the cancer patient: recent progress and ongoing questions.
abstract: In the last 5 years we have witnessed further developments in diagnosis and treatment of invasive fungal infections (IFIs) that complicate cancer chemotherapy. In this brief overview, we highlight some advancement, discuss future directions, and unmet needs in this complex area.
authors.affiliation: Division of Internal Medicine, University of Texas M. D. Anderson Cancer Center, Houston Department of Medicine, University of Texas Health Science Center at San Antonio, and South Texas Veterans Health Care System.
authors.forename: Dimitrios P
authors.initials: DP
authors.lastname: Kontoyiannis
authors.affiliation: Division of Internal Medicine, University of Texas M. D. Anderson Cancer Center, Houston Department of Medicine, University of Texas Health Science Center at San Antonio, and South Texas Veterans Health Care System.
authors.forename: Thomas F
authors.initials: TF
authors.lastname: Patterson
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002177:Candidiasis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D009181:Mycoses / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy*; D009369:Neoplasms / Q000150:complications*
chemical_list: D000935:Antifungal Agents
keywords: Aspergillosis; cancer; candidiasis; diagnosis; treatment